nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—Phenylpropanolamine—SLC6A3—malignant glioma	0.0465	0.422	CrCbGaD
Levonordefrin—Dopamine—SLC6A3—malignant glioma	0.0334	0.303	CrCbGaD
Levonordefrin—Epinephrine—TNF—malignant glioma	0.0303	0.275	CrCbGaD
Levonordefrin—ADRA2A—Metabolism—CAT—malignant glioma	0.00042	0.000472	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PDGFRA—malignant glioma	0.000419	0.000471	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTK2—malignant glioma	0.000418	0.00047	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—PIK3CA—malignant glioma	0.000418	0.00047	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CG—malignant glioma	0.000417	0.000469	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CXCL8—malignant glioma	0.000416	0.000468	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HES1—malignant glioma	0.000411	0.000462	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AKT2—malignant glioma	0.000411	0.000462	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PTPN11—malignant glioma	0.00041	0.000461	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NTRK1—malignant glioma	0.000409	0.000459	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NCOR1—malignant glioma	0.000408	0.000459	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOTCH2—malignant glioma	0.000407	0.000457	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SPP1—malignant glioma	0.000407	0.000457	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CXCL8—malignant glioma	0.000405	0.000455	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TP53—malignant glioma	0.000404	0.000454	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PIK3CD—malignant glioma	0.000404	0.000454	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—RAF1—malignant glioma	0.000403	0.000453	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—KNG1—malignant glioma	0.000398	0.000448	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CAV1—malignant glioma	0.000398	0.000448	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—IL2—malignant glioma	0.000398	0.000447	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NCOR1—malignant glioma	0.000397	0.000446	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3CD—malignant glioma	0.000395	0.000443	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PIK3CB—malignant glioma	0.000393	0.000442	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PDGFRA—malignant glioma	0.000391	0.00044	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL2—malignant glioma	0.000387	0.000435	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TERT—malignant glioma	0.000385	0.000433	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AKT2—malignant glioma	0.000382	0.000429	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MMP3—malignant glioma	0.00038	0.000427	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SPP1—malignant glioma	0.00038	0.000427	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NTRK1—malignant glioma	0.00038	0.000427	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PIK3CB—malignant glioma	0.000379	0.000426	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CXCL8—malignant glioma	0.000378	0.000425	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CDKN2B—malignant glioma	0.000376	0.000423	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PDGFB—malignant glioma	0.000376	0.000423	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FGFR1—malignant glioma	0.000374	0.000421	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—KRAS—malignant glioma	0.000369	0.000415	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HIF1A—malignant glioma	0.000369	0.000414	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CD—malignant glioma	0.000367	0.000412	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTK2—malignant glioma	0.000366	0.000411	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—AKT1—malignant glioma	0.000365	0.000411	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CXCL8—malignant glioma	0.000364	0.000409	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CG—malignant glioma	0.000363	0.000408	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL2—malignant glioma	0.000361	0.000406	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TERT—malignant glioma	0.00036	0.000405	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HES1—malignant glioma	0.000359	0.000404	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NCOR1—malignant glioma	0.000357	0.000401	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CAV1—malignant glioma	0.000356	0.000401	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MMP3—malignant glioma	0.000353	0.000397	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—KDR—malignant glioma	0.000352	0.000396	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—RAF1—malignant glioma	0.000352	0.000396	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PIK3CB—malignant glioma	0.000352	0.000396	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PDGFB—malignant glioma	0.000351	0.000395	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PPARG—malignant glioma	0.00035	0.000393	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CDKN2B—malignant glioma	0.00035	0.000393	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FGFR1—malignant glioma	0.00035	0.000393	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—IL2—malignant glioma	0.000348	0.000391	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HIF1A—malignant glioma	0.000344	0.000387	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3CB—malignant glioma	0.000344	0.000387	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PDGFRA—malignant glioma	0.000342	0.000384	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—AKT1—malignant glioma	0.000341	0.000384	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTK2—malignant glioma	0.00034	0.000382	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—PIK3CA—malignant glioma	0.000339	0.000382	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FN1—malignant glioma	0.000339	0.000381	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—F2—malignant glioma	0.000339	0.000381	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CXCL8—malignant glioma	0.000338	0.00038	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—BAD—malignant glioma	0.000335	0.000377	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HES1—malignant glioma	0.000334	0.000375	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CAV1—malignant glioma	0.000333	0.000374	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOTCH1—malignant glioma	0.000332	0.000373	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SPP1—malignant glioma	0.000332	0.000373	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NCOR1—malignant glioma	0.000332	0.000373	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	0.000331	0.000371	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—KDR—malignant glioma	0.000329	0.00037	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TP53—malignant glioma	0.000328	0.000369	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—RAF1—malignant glioma	0.000327	0.000368	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CD80—malignant glioma	0.000325	0.000366	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APC—malignant glioma	0.000325	0.000365	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CG—malignant glioma	0.000325	0.000365	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CAV1—malignant glioma	0.000323	0.000364	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—IL2—malignant glioma	0.000323	0.000363	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EGF—malignant glioma	0.000321	0.000361	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CB—malignant glioma	0.00032	0.000359	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PTPN11—malignant glioma	0.000319	0.000359	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CD—malignant glioma	0.000319	0.000358	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PDGFRA—malignant glioma	0.000318	0.000357	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—F2—malignant glioma	0.000317	0.000356	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FN1—malignant glioma	0.000317	0.000356	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL2—malignant glioma	0.000316	0.000355	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TERT—malignant glioma	0.000315	0.000354	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—BAD—malignant glioma	0.000313	0.000352	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOTCH1—malignant glioma	0.00031	0.000349	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SPP1—malignant glioma	0.000308	0.000347	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	0.000307	0.000345	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CXCL8—malignant glioma	0.000307	0.000345	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	0.000306	0.000343	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—BRAF—malignant glioma	0.000305	0.000343	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CD80—malignant glioma	0.000304	0.000342	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APC—malignant glioma	0.000303	0.000341	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CG—malignant glioma	0.000303	0.000341	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	0.000301	0.000338	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EGF—malignant glioma	0.0003	0.000337	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTPN11—malignant glioma	0.000298	0.000335	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKT2—malignant glioma	0.000297	0.000334	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—EGFR—malignant glioma	0.000296	0.000333	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CG—malignant glioma	0.000295	0.000331	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL2—malignant glioma	0.000293	0.00033	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TERT—malignant glioma	0.000292	0.000329	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CAV1—malignant glioma	0.000291	0.000327	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—KDR—malignant glioma	0.000288	0.000324	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CD—malignant glioma	0.000285	0.000321	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PDGFB—malignant glioma	0.000285	0.000321	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—BRAF—malignant glioma	0.000285	0.00032	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PPARG—malignant glioma	0.000284	0.00032	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FGFR1—malignant glioma	0.000284	0.000319	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—PIK3CA—malignant glioma	0.000283	0.000318	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HIF1A—malignant glioma	0.00028	0.000314	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—KRAS—malignant glioma	0.000279	0.000314	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CB—malignant glioma	0.000278	0.000312	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKT2—malignant glioma	0.000278	0.000312	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—AKT1—malignant glioma	0.000277	0.000312	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—F2—malignant glioma	0.000277	0.000311	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FN1—malignant glioma	0.000277	0.000311	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—EGFR—malignant glioma	0.000276	0.000311	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PTGS2—malignant glioma	0.000275	0.00031	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—BAD—malignant glioma	0.000274	0.000308	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FGF2—malignant glioma	0.000273	0.000307	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	0.000271	0.000305	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CAV1—malignant glioma	0.00027	0.000304	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—KDR—malignant glioma	0.000267	0.000301	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CD—malignant glioma	0.000267	0.0003	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CD80—malignant glioma	0.000266	0.000299	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APC—malignant glioma	0.000265	0.000298	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	0.000265	0.000298	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—PIK3CA—malignant glioma	0.000264	0.000297	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EGF—malignant glioma	0.000262	0.000295	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—KRAS—malignant glioma	0.000261	0.000293	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	0.000261	0.000293	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CD—malignant glioma	0.000259	0.000291	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—F2—malignant glioma	0.000257	0.000289	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FN1—malignant glioma	0.000257	0.000289	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—PIK3CA—malignant glioma	0.000257	0.000289	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MDM2—malignant glioma	0.000256	0.000287	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FGF2—malignant glioma	0.000255	0.000287	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RAF1—malignant glioma	0.000255	0.000286	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—BAD—malignant glioma	0.000254	0.000286	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ERBB2—malignant glioma	0.000252	0.000283	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	0.000252	0.000283	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—BRAF—malignant glioma	0.000249	0.00028	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CB—malignant glioma	0.000249	0.00028	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CD80—malignant glioma	0.000247	0.000277	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APC—malignant glioma	0.000246	0.000277	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	0.000246	0.000277	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EGF—malignant glioma	0.000244	0.000274	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKT2—malignant glioma	0.000243	0.000273	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	0.000242	0.000272	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	0.000242	0.000272	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PTEN—malignant glioma	0.00024	0.00027	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	0.00024	0.00027	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	0.000239	0.000269	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MDM2—malignant glioma	0.000239	0.000268	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RAF1—malignant glioma	0.000238	0.000268	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	0.000236	0.000265	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	0.000233	0.000262	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	0.000232	0.000261	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—BRAF—malignant glioma	0.000232	0.00026	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	0.000231	0.00026	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	0.000231	0.00026	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CASP3—malignant glioma	0.000229	0.000257	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL2—malignant glioma	0.000229	0.000257	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	0.000228	0.000256	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CB—malignant glioma	0.000226	0.000254	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKT2—malignant glioma	0.000225	0.000253	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	0.000224	0.000252	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTGS2—malignant glioma	0.000224	0.000251	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	0.000223	0.000251	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FGF2—malignant glioma	0.000223	0.000251	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	0.000217	0.000243	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MMP9—malignant glioma	0.000216	0.000243	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	0.000216	0.000242	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PTEN—malignant glioma	0.000215	0.000242	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	0.000215	0.000241	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CASP3—malignant glioma	0.000214	0.00024	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL2—malignant glioma	0.000213	0.00024	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	0.000212	0.000238	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	0.00021	0.000236	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	0.00021	0.000236	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MDM2—malignant glioma	0.000209	0.000235	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RAF1—malignant glioma	0.000208	0.000234	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FGF2—malignant glioma	0.000207	0.000233	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	0.000206	0.000231	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	0.000203	0.000228	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MMP9—malignant glioma	0.000202	0.000227	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTEN—malignant glioma	0.000201	0.000226	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	0.000196	0.00022	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	0.000195	0.000219	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTEN—malignant glioma	0.000195	0.000219	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	0.000195	0.000219	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	0.000194	0.000218	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MDM2—malignant glioma	0.000194	0.000218	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RAF1—malignant glioma	0.000193	0.000217	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—STAT3—malignant glioma	0.000192	0.000216	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	0.000191	0.000215	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	0.000189	0.000212	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	0.000189	0.000212	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CASP3—malignant glioma	0.000187	0.00021	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL2—malignant glioma	0.000187	0.00021	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	0.000181	0.000204	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	0.000181	0.000204	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—STAT3—malignant glioma	0.00018	0.000202	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MYC—malignant glioma	0.000179	0.000201	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MMP9—malignant glioma	0.000177	0.000198	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTEN—malignant glioma	0.000176	0.000197	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	0.000175	0.000197	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EGFR—malignant glioma	0.000175	0.000196	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CASP3—malignant glioma	0.000174	0.000195	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL2—malignant glioma	0.000173	0.000195	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	0.000171	0.000193	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CA—malignant glioma	0.000169	0.00019	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MYC—malignant glioma	0.000167	0.000188	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—KRAS—malignant glioma	0.000165	0.000186	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MMP9—malignant glioma	0.000164	0.000184	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EGFR—malignant glioma	0.000163	0.000183	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTEN—malignant glioma	0.000163	0.000183	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	0.000159	0.000179	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	0.000159	0.000178	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—STAT3—malignant glioma	0.000157	0.000176	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—KRAS—malignant glioma	0.000154	0.000173	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	0.000152	0.00017	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	0.000147	0.000166	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TP53—malignant glioma	0.000147	0.000165	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MYC—malignant glioma	0.000146	0.000164	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—STAT3—malignant glioma	0.000146	0.000164	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EGFR—malignant glioma	0.000143	0.00016	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	0.000142	0.000159	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—AKT1—malignant glioma	0.000138	0.000156	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CA—malignant glioma	0.000138	0.000155	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TP53—malignant glioma	0.000137	0.000154	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MYC—malignant glioma	0.000136	0.000152	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—KRAS—malignant glioma	0.000135	0.000152	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EGFR—malignant glioma	0.000133	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—KRAS—malignant glioma	0.000125	0.000141	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKT1—malignant glioma	0.000124	0.000139	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	0.000124	0.000139	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TP53—malignant glioma	0.00012	0.000135	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKT1—malignant glioma	0.000116	0.00013	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	0.000115	0.000129	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AKT1—malignant glioma	0.000112	0.000126	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TP53—malignant glioma	0.000111	0.000125	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKT1—malignant glioma	0.000101	0.000114	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKT1—malignant glioma	9.4e-05	0.000106	CbGpPWpGaD
